Search Results

There are 14067 results for: content related to: A pilot study of adalimumab in infliximab-allergic patients

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 8, August 2015, Pages: 1576–1581, R. Bissonnette, C. Maari, K. Barber, C.W. Lynde and R. Vender

    Version of Record online : 20 JAN 2015, DOI: 10.1111/jdv.12943

  4. You have free access to this content
    Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 11-12, December 2007, Pages: 1509–1520, G. G. KAPLAN, C. HUR, J. KORZENIK and B. E. SANDS

    Version of Record online : 11 OCT 2007, DOI: 10.1111/j.1365-2036.2007.03548.x

  5. You have free access to this content
    TNF-alpha inhibitors for ankylosing spondylitis

    Intervention Review

    The Cochrane Library

    Lara J Maxwell, Jane Zochling, Annelies Boonen, Jasvinder A Singh, Mirella MS Veras, Elizabeth Tanjong Ghogomu, Maria Benkhalti Jandu, Peter Tugwell and George A Wells

    Published Online : 18 APR 2015, DOI: 10.1002/14651858.CD005468.pub2

  6. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Amy S Mudano, Elizabeth Tanjong Ghogomu, Maria E Suarez-Almazor, Rachelle Buchbinder, Lara J Maxwell, Peter Tugwell and George A Wells

    Published Online : 8 MAY 2017, DOI: 10.1002/14651858.CD012657

  7. You have free access to this content
    Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: Results in a single community-based hospital

    The Journal of Dermatology

    Volume 39, Issue 3, March 2012, Pages: 265–268, Shinji NODA, Kyoko MIZUNO and Makoto ADACHI

    Version of Record online : 29 NOV 2011, DOI: 10.1111/j.1346-8138.2011.01312.x

  8. You have free access to this content
    Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1296–1309, R. PANACCIONE, J.-F. COLOMBEL, W. J. SANDBORN, P. RUTGEERTS, G. R. D’HAENS, A. M. ROBINSON, J. CHAO, P. M. MULANI and P. F. POLLACK

    Version of Record online : 18 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04304.x

  9. You have free access to this content
    Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 11-12, December 2014, Pages: 1324–1332, F. Baert, N. Vande Casteele, S. Tops, M. Noman, G. Van Assche, P. Rutgeerts, A. Gils, S. Vermeire and M. Ferrante

    Version of Record online : 2 OCT 2014, DOI: 10.1111/apt.12968

  10. You have free access to this content
    Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis

    The Journal of Dermatology

    Volume 40, Issue 1, January 2013, Pages: 39–42, Hidetoshi Takahashi, Hitomi Tsuji, Akemi Ishida-Yamamoto and Hajime Iizuka

    Version of Record online : 5 OCT 2012, DOI: 10.1111/j.1346-8138.2012.01679.x

  11. Short-term response to adalimumab in childhood inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 14, Issue 12, December 2008, Pages: 1683–1687, Joshua D. Noe and Marian Pfefferkorn

    Version of Record online : 10 JUL 2008, DOI: 10.1002/ibd.20534

  12. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis

    British Journal of Dermatology

    Volume 167, Issue s3, November 2012, Pages: 12–20, J. Leman and A.D. Burden

    Version of Record online : 22 OCT 2012, DOI: 10.1111/j.1365-2133.2012.11209.x

  13. You have free access to this content
    Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 1044–1055, C. Ma, V. Huang, D. K. Fedorak, K. I. Kroeker, L. A. Dieleman, B. P. Halloran and R. N. Fedorak

    Version of Record online : 3 SEP 2014, DOI: 10.1111/apt.12940

  14. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Lara J Maxwell, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor, Peter Tugwell and George A Wells

    Published Online : 10 MAR 2017, DOI: 10.1002/14651858.CD012591

  15. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 9, September 2015, Pages: 1742–1749, P. Sator, L. Richter, W. Saxinger, M. Vasiljevic and G. Stingl

    Version of Record online : 9 FEB 2015, DOI: 10.1111/jdv.12981

  16. You have free access to this content
    Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

    British Journal of Clinical Pharmacology

    Volume 79, Issue 2, February 2015, Pages: 286–297, David Ternant, Emilie Ducourau, Piéra Fuzibet, Céline Vignault, Hervé Watier, Thierry Lequerré, Xavier Le Loët, Olivier Vittecoq, Philippe Goupille, Denis Mulleman and Gilles Paintaud

    Version of Record online : 20 JAN 2015, DOI: 10.1111/bcp.12509

  17. Abstracts from the 2008 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's National Clinical & Research Conference

    Inflammatory Bowel Diseases

    Volume 14, Issue S3, December 2008, Pages: S1–S49,

    Version of Record online : 26 NOV 2008, DOI: 10.1002/ibd.20829

  18. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu and Peter Tugwell

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007848.pub2

  19. Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis

    British Journal of Dermatology

    Volume 170, Issue 4, April 2014, Pages: 922–929, T. Bito, R. Nishikawa, M. Hatakeyama, A. Kikusawa, H. Kanki, H. Nagai, Y. Sarayama, T. Ikeda, H. Yoshizaki, H. Seto, A. Adachi, T. Horikawa, M. Oka and C. Nishigori

    Version of Record online : 15 APR 2014, DOI: 10.1111/bjd.12791

  20. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara J Maxwell, John K MacDonald, Graziella Filippini, Nicole Skoetz, Damian K Francis, Luciane C Lopes, Gordon H Guyatt, Jochen Schmitt, Loredana La Mantia, Tobias Weberschock, Juliana F Roos, Hendrik Siebert, Sarah Hershan, Chris Cameron, Michael PT Lunn, Peter Tugwell and Rachelle Buchbinder

    Published Online : 16 FEB 2011, DOI: 10.1002/14651858.CD008794.pub2